Editas Medicine Inc (EDIT)
2.43
+0.06
(+2.53%)
USD |
NASDAQ |
Nov 22, 10:04
Editas Medicine Price: 2.43 for Nov. 22, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 21, 2024 | 2.45 | 2.47 | 2.30 | 2.37 | 2.889M |
| Nov 20, 2024 | 2.47 | 2.475 | 2.35 | 2.41 | 2.818M |
| Nov 19, 2024 | 2.51 | 2.56 | 2.47 | 2.48 | 2.090M |
| Nov 18, 2024 | 2.69 | 2.69 | 2.51 | 2.52 | 2.110M |
| Nov 15, 2024 | 2.80 | 2.80 | 2.59 | 2.66 | 2.503M |
| Nov 14, 2024 | 2.96 | 2.98 | 2.76 | 2.77 | 1.709M |
| Nov 13, 2024 | 3.15 | 3.20 | 2.95 | 2.96 | 1.224M |
| Nov 12, 2024 | 3.25 | 3.252 | 3.045 | 3.07 | 1.509M |
| Nov 11, 2024 | 3.17 | 3.375 | 3.15 | 3.30 | 2.253M |
| Nov 08, 2024 | 3.16 | 3.235 | 3.07 | 3.12 | 1.653M |
| Nov 07, 2024 | 3.27 | 3.30 | 3.11 | 3.17 | 2.079M |
| Nov 06, 2024 | 3.33 | 3.40 | 3.060 | 3.28 | 4.226M |
| Nov 05, 2024 | 2.86 | 3.17 | 2.79 | 3.12 | 2.152M |
| Nov 04, 2024 | 2.90 | 3.075 | 2.70 | 2.88 | 3.952M |
| Nov 01, 2024 | 2.92 | 3.03 | 2.90 | 2.91 | 1.877M |
| Oct 31, 2024 | 3.03 | 3.03 | 2.90 | 2.90 | 1.967M |
| Oct 30, 2024 | 3.06 | 3.145 | 3.005 | 3.02 | 1.694M |
| Oct 29, 2024 | 3.26 | 3.36 | 3.06 | 3.11 | 2.198M |
| Oct 28, 2024 | 3.19 | 3.32 | 3.19 | 3.26 | 1.341M |
| Oct 25, 2024 | 3.17 | 3.355 | 3.17 | 3.18 | 1.171M |
| Oct 24, 2024 | 3.19 | 3.215 | 3.061 | 3.18 | 1.693M |
| Oct 23, 2024 | 3.28 | 3.308 | 3.165 | 3.21 | 2.392M |
| Oct 22, 2024 | 3.75 | 3.75 | 3.23 | 3.29 | 3.333M |
| Oct 21, 2024 | 3.35 | 3.80 | 3.28 | 3.76 | 4.587M |
| Oct 18, 2024 | 3.32 | 3.409 | 3.315 | 3.36 | 860257.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.37
Minimum
Nov 21 2024
90.58
Maximum
Jan 08 2021
21.72
Average
15.61
Median
Feb 17 2022
Price Benchmarks
| Ionis Pharmaceuticals Inc | 34.30 |
| EyePoint Pharmaceuticals Inc | 8.45 |
| Cassava Sciences Inc | 27.78 |
| Adverum Biotechnologies Inc | 5.80 |
| Regenxbio Inc | 9.20 |
Price Related Metrics
| PS Ratio | 3.231 |
| Price to Book Value | 1.142 |
| Earnings Yield | -105.3% |
| Market Cap | 200.59M |